Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MAZE

Maze Therapeutics, Inc.

CIK 0001842295 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$32.42
↑ 0.43 (1.34%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.79B
P/E Ratio
-14.64
EPS
-3.05
Dividend Yield
Not covered
52W Position
48%
Beta
1.09

Valuation multiples

Fwd P/E
8.53
PEG
Not covered
P/B
5.25
P/S
Not covered
EV/Revenue
Not covered
ROE
-35.9%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 48%
$12.81$53.65

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$131.12M
Total Assets
$397.13M
Free Cash Flow
-$112.73M

Recent news